Literature DB >> 33346798

HIV Prevention Trials Network 078: High Prevalence of Hepatitis C Virus Antibodies Among Urban US Men Who Have Sex With Men, Independent of Human Immunodeficiency Virus Status.

Risha Irvin1, Theresa Gamble2, Jowanna Malone1, Zhe Wang3, Ethan Wilson3, James P Hughes4, Jason Farley1, Kenneth H Mayer5, Carlos Del Rio6, D Scott Batey7, Vanessa Cummings1, Robert H Remien8, Chris Beyrer1, Chloe L Thio1.   

Abstract

BACKGROUND: Sexual transmission of hepatitis C virus (HCV) is uncommon, yet documented among men who have sex with men (MSM), primarily among those with human immunodeficiency virus (HIV).
METHODS: In the HIV Prevention Trials Network 078 study (HPTN 078), which assessed an integrated strategy to achieve HIV viral suppression, 1305 MSM were screened across 4 geographically diverse US cities. At screening, demographic/behavioral/psychosocial questionnaires were completed, along with HIV and HCV testing. Multivariable logistic regression was used to evaluate associations with HCV antibody positivity.
RESULTS: Among the 1287 (99%) of the MSM with HCV antibody results, the median age was 41, 69% were black, 85% had a high school education or more, 35% were employed, 70% had HIV, and 21% had undergone substance use counseling. The median lifetime number of male sexual partners was 17 (interquartile range, 6-50), and 246 (19%) were HCV antibody positive. HCV antibody positivity was high in MSM with HIV (20%) and MSM without HIV (17%) (P = .12) and was higher in those receiving substance use counseling (36%) than in those who had not (15%) (P ≤ .01). Substance use counseling (odds ratio, 2.51; 95% confidence interval, 1.80-3.51) and unstable housing (2.16; 1.40-3.33) were associated with HCV antibody positivity.
CONCLUSIONS: Nearly 1 in 5 MSM screened for HPTN 078 have been infected with HCV. The prevalence is high regardless of HIV status and is high even in those who did not undergo substance use counseling. In HIV burden networks, high HCV infection prevalence may occur in MSM without HIV. As implementation of preexposure prophylaxis expands and condom use declines, routine HCV counseling and screening among MSM are important.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; hepatitis C; men who have sex with men

Mesh:

Substances:

Year:  2021        PMID: 33346798      PMCID: PMC8492204          DOI: 10.1093/cid/ciaa1869

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  41 in total

1.  Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.

Authors:  Emma Day; Tina Broder; Julie Bruneau; Sally Cruse; Melisa Dickie; Suzanne Fish; Celine Grillon; Niklas Luhmann; Kate Mason; Elizabeth McLean; Stacey Trooskin; Carla Treloar; Jason Grebely
Journal:  Int J Drug Policy       Date:  2019-02-08

Review 2.  Global Elimination of Chronic Hepatitis.

Authors:  David L Thomas
Journal:  N Engl J Med       Date:  2019-05-23       Impact factor: 91.245

3.  Micro-elimination - A path to global elimination of hepatitis C.

Authors:  Jeffrey V Lazarus; Stefan Wiktor; Massimo Colombo; Mark Thursz
Journal:  J Hepatol       Date:  2017-07-29       Impact factor: 25.083

4.  High HIV, hepatitis C and sexual risks among drug-using men who have sex with men in northern Thailand.

Authors:  Chris Beyrer; Teerada Sripaipan; Sodsai Tovanabutra; Jaroon Jittiwutikarn; Vinai Suriyanon; Tasanai Vongchak; Namtip Srirak; Surinda Kawichai; Myat Htoo Razak; David D Celentano
Journal:  AIDS       Date:  2005-09-23       Impact factor: 4.177

5.  High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.

Authors:  Elske Hoornenborg; Liza Coyer; Anders Boyd; Roel Christiaan Alfons Achterbergh; Maarten Franciscus Schim van der Loeff; Sylvia Bruisten; Henry John Christiaan de Vries; Jelle Koopsen; Thijs J W van de Laar; Maria Prins
Journal:  J Hepatol       Date:  2019-12-18       Impact factor: 25.083

Review 6.  Correlates of hepatitis C virus infections among injection drug users.

Authors:  D L Thomas; D Vlahov; L Solomon; S Cohn; E Taylor; R Garfein; K E Nelson
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889

7.  Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs.

Authors:  Risha Irvin; Geetanjali Chander; Oluwaseun Falade-Nwulia; Jacquie Astemborski; Laura Starbird; Gregory D Kirk; Mark S Sulkowski; David L Thomas; Shruti H Mehta
Journal:  Addict Behav       Date:  2019-04-23       Impact factor: 4.591

8.  Examining levels of risk behaviors among black men who have sex with Men (MSM) and the association with HIV acquisition.

Authors:  Risha Irvin; Snigdha Vallabhaneni; Hyman Scott; John K Williams; Leo Wilton; Xin Li; Susan Buchbinder
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

9.  Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans.

Authors:  Amanda J Noska; Pamela S Belperio; Timothy P Loomis; Thomas P O'Toole; Lisa I Backus
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079

10.  Sampling Key Populations for HIV Surveillance: Results From Eight Cross-Sectional Studies Using Respondent-Driven Sampling and Venue-Based Snowball Sampling.

Authors:  Amrita Rao; Shauna Stahlman; James Hargreaves; Sharon Weir; Jessie Edwards; Brian Rice; Duncan Kochelani; Mpumelelo Mavimbela; Stefan Baral
Journal:  JMIR Public Health Surveill       Date:  2017-10-20
View more
  1 in total

Review 1.  Advances in Liver Transplantation for Persons with Human Immunodeficiency Infection.

Authors:  Rebecca N Kumar; Valentina Stosor
Journal:  Curr Infect Dis Rep       Date:  2022-03-15       Impact factor: 3.663

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.